Search research articles
Contact Us
Filters
Showing results (21-30 of 25) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 25 results.
Cell Research
|
September 1, 2010
Physiological levels of ATP negatively regulate proteasome function
Hongbiao Huang, Xiaoyan Zhang, Shujue Li, et al.
Frontiers in Bioscience (Elite Edition)
|
May 31, 2011
Sanggenon C decreases tumor cell viability associated with proteasome inhibition
Hongbiao Huang, Ningning Liu, Kai Zhao, et al.
Cell Reports
|
December 25, 2012
Gambogic acid is a tissue-specific proteasome inhibitor in vitro and in vivo
Xiaofen Li, Shouting Liu, Hongbiao Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 16, 2026
Improving anti-CTLA-4 therapies through peptide masking and fragment crystallizable non‑fucosylation: preclinical characterization of three novel antibodies
Amy Jhatakia, Xin Sun, Alessandra Vaccaro, et al.
Nature Medicine
|
March 17, 2023
Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial
Tina Cascone, Cheuk H Leung, Annikka Weissferdt, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 25) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 25 results.
Cell Research
|
September 1, 2010
Physiological levels of ATP negatively regulate proteasome function
Hongbiao Huang, Xiaoyan Zhang, Shujue Li, et al.
Frontiers in Bioscience (Elite Edition)
|
May 31, 2011
Sanggenon C decreases tumor cell viability associated with proteasome inhibition
Hongbiao Huang, Ningning Liu, Kai Zhao, et al.
Cell Reports
|
December 25, 2012
Gambogic acid is a tissue-specific proteasome inhibitor in vitro and in vivo
Xiaofen Li, Shouting Liu, Hongbiao Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 16, 2026
Improving anti-CTLA-4 therapies through peptide masking and fragment crystallizable non‑fucosylation: preclinical characterization of three novel antibodies
Amy Jhatakia, Xin Sun, Alessandra Vaccaro, et al.
Nature Medicine
|
March 17, 2023
Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial
Tina Cascone, Cheuk H Leung, Annikka Weissferdt, et al.
Page
of 3